Denali Therapeutics, Inc. (DNLI)
19.45
+0.04
(+0.21%)
USD |
NASDAQ |
Apr 08, 15:19
Denali Therapeutics Market Cap : 3.085B for April 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Protalix Biotherapeutics, Inc. | 178.87M |
| Agenus, Inc. | 161.27M |
| Curis, Inc. | 22.03M |
| Plus Therapeutics, Inc. | 21.24M |
| Windtree Therapeutics, Inc. | 0.4109M |
Market Cap Related Metrics
| PEG Ratio | -0.4283 |
| Price to Book Value | 3.043 |
| Price | 19.45 |
| Earnings Yield | -15.27% |
| PEGY Ratio | -0.4283 |